The article directly mentions Curaleaf Holdings Inc and its executive chairman's positive outlook for 2024, highlighting regulatory changes and market expansions as key growth drivers. The potential rescheduling of cannabis in the U.S. could significantly reduce tax burdens and attract institutional investment, which would likely have a positive impact on Curaleaf's financials and stock price. The company's recent uplift to the TSX and expected custodianship by major banks are also seen as positive developments that could facilitate investment and improve stock ownership structures.